Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

1.9K
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
1.9K
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

2.4K
Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.4K
Target Cell Response to Hormones01:22

Target Cell Response to Hormones

4.1K
Hormones intricately bind to receptors on the surface or within target cells, initiating a cascade of cellular responses.
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
4.1K
Internal Receptors01:31

Internal Receptors

72.1K
Many cellular signals are hydrophilic and therefore cannot pass through the plasma membrane. However, small or hydrophobic signaling molecules can cross the hydrophobic core of the plasma membrane and bind to internal, or intracellular, receptors that reside within the cell. Many mammalian steroid hormones use this mechanism of cell signaling, as does nitric oxide (NO) gas.
72.1K
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

2.7K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.7K
Types of Receptors: Internal Receptors01:07

Types of Receptors: Internal Receptors

28.2K
Many cellular signals are hydrophilic and cannot pass through the plasma membrane. However, small or hydrophobic signaling molecules can cross the hydrophobic core of the plasma membrane and bind intracellular receptors that reside within the cell cytoplasm or nucleus. Many mammalian steroid hormones and nitric oxide (NO) gas use this cell signaling mechanism.
Similar to membrane-bound receptors, the binding of a ligand to the intracellular receptor of causes a conformational change in the...
28.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Involvement of Intestinal Epithelium Aryl Hydrocarbon Receptor Expression and 3, 3'-Diindolylmethane in Colonic Tertiary Lymphoid Tissue Formation.

International journal of molecular sciences·2024
Same author

Aryl hydrocarbon receptor activity in intestinal epithelial cells in the formation of colonic tertiary lymphoid tissues.

American journal of physiology. Gastrointestinal and liver physiology·2024
Same author

Estrogen Protects Cardiac Function and Energy Metabolism in Dilated Cardiomyopathy Induced by Loss of Cardiac IRS1 and IRS2.

Circulation. Heart failure·2022
Same author

Loss of Aryl Hydrocarbon Receptor Promotes Colon Tumorigenesis in <i>Apc</i> Mice.

Molecular cancer research : MCR·2021
Same author

Effects of high-fat diet and intestinal aryl hydrocarbon receptor deletion on colon carcinogenesis.

American journal of physiology. Gastrointestinal and liver physiology·2020
Same author

Effect of combined fish oil & Curcumin on murine skeletal muscle morphology and stress response proteins during mechanical unloading.

Nutrition research (New York, N.Y.)·2019

Related Experiment Video

Updated: Oct 26, 2025

Visualization of Estrogen Receptors in Colons of Mice with TNBS-Induced Crohn's Disease using Immunofluorescence
08:02

Visualization of Estrogen Receptors in Colons of Mice with TNBS-Induced Crohn's Disease using Immunofluorescence

Published on: March 12, 2020

6.8K

Estrogen receptor actions in colitis.

Erika L Garcia-Villatoro1, Clinton D Allred2

  • 1Department of Nutrition, Texas A&M University, United States.

Essays in Biochemistry
|August 3, 2021
PubMed
Summary

Estrogen and its receptors influence inflammatory bowel diseases (IBDs) like ulcerative colitis and Crohn's disease. This review explores estrogen receptor beta's role in IBD pathophysiology.

Keywords:
IBDcolitisestrogenestrogen receptorinflammation

More Related Videos

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
06:18

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on: August 13, 2019

12.4K
Detecting the Ligand-binding Domain Dimerization Activity of Estrogen Receptor Alpha Using the Mammalian Two-Hybrid Assay
09:07

Detecting the Ligand-binding Domain Dimerization Activity of Estrogen Receptor Alpha Using the Mammalian Two-Hybrid Assay

Published on: December 19, 2018

6.5K

Related Experiment Videos

Last Updated: Oct 26, 2025

Visualization of Estrogen Receptors in Colons of Mice with TNBS-Induced Crohn's Disease using Immunofluorescence
08:02

Visualization of Estrogen Receptors in Colons of Mice with TNBS-Induced Crohn's Disease using Immunofluorescence

Published on: March 12, 2020

6.8K
An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
06:18

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on: August 13, 2019

12.4K
Detecting the Ligand-binding Domain Dimerization Activity of Estrogen Receptor Alpha Using the Mammalian Two-Hybrid Assay
09:07

Detecting the Ligand-binding Domain Dimerization Activity of Estrogen Receptor Alpha Using the Mammalian Two-Hybrid Assay

Published on: December 19, 2018

6.5K

Area of Science:

  • Endocrinology
  • Gastroenterology
  • Immunology

Background:

  • Estrogen and its receptors play a role in inflammatory bowel diseases (IBDs), including ulcerative colitis (UC) and Crohn's disease (CD).
  • Epidemiological data show sex-based differences in IBD incidence, severity, and complications, with men having a higher risk of colitis and colorectal cancer.
  • Estrogen level fluctuations and therapies show inconsistent effects on IBDs, with varying impacts based on menopausal status and pregnancy.

Purpose of the Study:

  • To review the role of estrogen and its receptors, particularly estrogen receptor beta (ERβ), in the pathophysiology of IBDs.
  • To consolidate current understanding of how estrogen signaling impacts the development and progression of inflammatory bowel diseases.

Main Methods:

  • Literature review of preclinical and clinical studies on estrogen, its receptors, and IBDs.
  • Analysis of epidemiological data regarding sex differences in IBDs.
  • Examination of the expression and function of estrogen receptor beta (ERβ) in the colonic epithelium.

Main Results:

  • Estrogen receptor beta (ERβ) is the predominant estrogen receptor in the colonic epithelium, crucial for normal function.
  • Preclinical data indicate that estrogen receptor expression and activation can differentially affect colitis severity depending on the experimental model.
  • Observed inconsistencies in estrogen's effects (e.g., hormone therapy, pregnancy) suggest complex interactions in IBD pathogenesis.

Conclusions:

  • Estrogen and its receptors, especially ERβ, are implicated in the pathophysiology of inflammatory bowel diseases.
  • Understanding these interactions is crucial for explaining sex-based differences and developing targeted therapies for IBDs.
  • Further research is needed to elucidate the precise mechanisms of estrogen signaling in UC and CD.